Navigation Links
WuXi PharmaTech Expands Collaboration for Fully Integrated Services
Date:10/16/2008

SHANGHAI, China, Oct. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica, N.V. (J&JPRD) to expand its pharmaceutical R&D services collaboration.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOG )

The new broad agreement aims to deepen the already long-standing relationship between J&JPRD and WuXi PharmaTech. WuXi, already a preferred research services provider to J&JPRD for discovery chemistry, will now provide integrated research services in the area of discovery chemistry, discovery biology, chemical and analytical development services, formulation, and preclinical and bio-analytical services, to enhance drug discovery and shorten development timelines.

Commenting on the agreement, Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech, said, "We are very pleased to expand our partnership with J&JPRD. This agreement leverages WuXi's strong R&D capabilities from early stage discovery to commercial production to deliver reliable, high quality and cost-efficient services to J&JPRD. Our partnership demonstrates the strength of our innovation driven and fully integrated R&D service platform."

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focu
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007
2. WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award
3. WuXi PharmaTech Announces Third Quarter 2007 Results
4. WestChina-Frontier PharmaTech Awarded Full AAALAC Accreditation
5. WuXi PharmaTech (NYSE: WX) Mourns the Tragic Loss of Its Independent Director Shawn Wang
6. WuXi PharmaTech (NYSE: WX) Names Temporary Chairman of the Audit Committee
7. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
8. WuXi PharmaTech Announces Postponement of Proposed Follow-on Offering
9. Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars
10. The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX)
11. WuXi PharmaTech 2007 Annual Report Available Online

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Biotech firm Replikins Ltd. today is...irus genomic data. It shows that the lethality of...4.5) during the virus,s current outbreak in the sp...eek of 2.0 (s.d. 0.1). The H1N1 infectivity count,... Boston (PRWEB) November 27, 2009 -- Biotech ...
(Date:11/27/2009)...AN FRANCISCO, Nov. 27 Th...that Blair Lambert, CFO/COO, will present at the N...d at the May Fair Hotel in London, England, on Wed... To listen to a live broadcast of The Gymboree Cor...log on to www.gymboree.com, click on "Our Company"...
(Date:11/27/2009)..., NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswire/ ...essional cycling team dedicated to ethical sportin...ampions, announced today that it will become Team ...s Optical as a new sponsor of the team. Transition...daptive eyewear, offering the most advanced photoc...
(Date:11/27/2009)... XenaCare Holdings has announced that... Foundation, one of the largest nonprofit organiza...ealth education. , Delray...oldings, Inc. (OTCBB: XCHO), a company specializin...umer healthcare products, has announced today that...
(Date:11/27/2009)...s to bring unprecedented medical, economic burdens...althDay News) -- The number of people with diabete...the next 25 years, a new study predicts. , That...on people with the disease, up from 23.7 million t... people with diabetes will triple, the study also ...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3
... of the Bioniche Board of Directors since 1999 ... April 18 /PRNewswire-FirstCall/ - Bioniche Life,S...ogy-driven Canadian,biopharmaceutical company, tod...the Company,s President & CEO. "As Board Chair, Mr...
...ime by Half, ROSEVILLE, Calif., April 18 CoolTou...rs, announced today the introduction,of their new ...e set,designed specifically to be used with the Co...hich dramatically reduces,the time of the laser li...
...When Wiley Coyote goes,hungry in cartoon land, it,...l world, Roadrunner Food Bank wins when nobody goe...n/prnh/20080417/LATH545-a ), (Photo: http://www....nk to highlight the tragedy of hunger in New,Mexic...
...us Foundation of,America (LFA) is seeking proposal...c, clinical, or translational research studies on ...immune disease. The purposes of the,studies are to...ood, or pediatric, lupus; neuropsychiatric lupus;,...
... Changes to Create a Sustainable Model for ...ril 17 Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: Z...orporate compliance model aimed at establishing an... needs and better serve,the healthcare markets of ...
...U.S. Agency for,International Development and Iraq...um of Understanding (MOU) outlining a shared visio...the health sector,s ability to,deliver health serv... MoH and,USAID,s Tatweer initiative. As part of US...
Other Medicine News:Health News:Bioniche Reports the Passing of its Board Chair 2Health News:CoolTouch Introduces CoolBlue Duet(TM) Laser Lipolysis Suction Handpiece 2Health News:BEEP BEEP!! Strategic Communications Firm DW Turner Thwarts Hunger in Partnership With Roadrunner Food Bank 2Health News:Lupus Foundation of America Seeks Funding Proposals for Research Studies on Childhood Lupus, Nervous System Involvement, and More 2Health News:Zimmer Announces New Compliance Model 2Health News:Zimmer Announces New Compliance Model 3Health News:Zimmer Announces New Compliance Model 4Health News:Zimmer Announces New Compliance Model 5Health News:Zimmer Announces New Compliance Model 6Health News:Zimmer Announces New Compliance Model 7Health News:Iraq's Ministry of Health and USAID Sign Memorandum of Understanding to Increase Cooperation in Public Management 2
(Date:11/25/2009)...v. 25 Reportlinker.com announces t...ts catalogue: ,, Intranasal Drug Delivery - US...inker.com/p0164267/Intranasal-Drug-Delivery---US-M...al drug delivery market is witnessing an expansion...conventional local therapeutic drugs to the delive...
(Date:11/25/2009).... and SYDNEY, Nov. 25 He...HIN), a leading innovator and provider of less inv...es revolutionizing the treatment of advanced heart...make an investor presentation at the 21st Annual P... on Wednesday, December 2, 2009. The conference is...
(Date:11/24/2009)... Md., Nov. 24 /PRNewswire-Asia/ -- Chindex Interna...ng independent American provider of Western,health...c of China, today,announced that the Company will ...ealth Care Conference, to be held December 1 - 2, ...agement is currently scheduled to present at 11:30...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Chindex International to Present at Piper Jaffray Health Care Conference 2The doctor can understand you now 57848 1The doctor can understand you now 57848 2The doctor can understand you now 57848 3New device finds early signs of eye disease in preemies 57843 1New device finds early signs of eye disease in preemies 57843 2Growing outcomes evidence spurs renewed interest in unique heart valve procedure 10008 1Growing outcomes evidence spurs renewed interest in unique heart valve procedure 10008 2
...c., the recognized leader and trusted resource for...oday announced that it has signed an agreement wit...dical Center). KU Medical Center will deploy Velos...t that supports the regulatory, administrative, fi...itution,s clinical research programs. , , KU ...
... announced that the U.S. Food and Drug Administrat...uirements for the Biologics License Application (B...eukin-6 (IL-6) receptor-inhibiting monoclonal anti...ith moderately to severely active rheumatoid arthr...ving Risk Evaluation and Mitigation Strategy (REMS...
Other Medicine Technology:University of Kansas Medical Center to Deploy Velos eResearch System-Wide 2University of Kansas Medical Center to Deploy Velos eResearch System-Wide 3Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 2Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 3Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 4Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab) 5
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: